We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Xenon Pharmaceuticals
XENE
$6.32B
| $298K | 0.14% |
+8,872
| New | +$337K |
|
327
Molson Coors Class B
TAP
$7.68B
| $297K | 0.14% |
+4,886
| New | +$281K |
|
328
Merit Medical Systems
MMSI
$4.43B
| $297K | 0.14% |
2,806
-1,293
| -32% | -$133K |
|
329
Arteris
AIP
$1.4B
| $294K | 0.13% |
42,517
+22,703
| +115% | +$217K |
|
|
CPRX
330
DELISTED
Catalyst Pharmaceutical
CPRX
| $294K | 0.13% |
+12,115
| New | +$273K |
|
331
Personalis
PSNL
$1.26B
| $294K | 0.13% |
83,628
+36,115
| +76% | +$172K |
|
332
S&T Bancorp
STBA
$1.86B
| $293K | 0.13% |
+7,910
| New | +$304K |
|
333
Reliance Steel & Aluminium
RS
$20.8B
| $292K | 0.13% |
+1,012
| New | +$290K |
|
334
Upbound Group
UPBD
$1.19B
| $292K | 0.13% |
+12,175
| New | +$334K |
|
335
Blue Bird Corp
BLBD
$2.41B
| $291K | 0.13% |
+8,995
| New | +$329K |
|
336
Jefferies Financial Group
JEF
$12.9B
| $291K | 0.13% |
+5,423
| New | +$368K |
|
|
TEM
337
Tempus AI
TEM
$7.69B
| $290K | 0.13% |
+6,019
| New | +$325K |
|
338
Motorola Solutions
MSI
$69.4B
| $290K | 0.13% |
662
+177
| +36% | +$79K |
|
339
APA Corp
APA
$12.8B
| $290K | 0.13% |
+13,774
| New | +$303K |
|
340
Coupang
CPNG
$27.8B
| $289K | 0.13% |
+13,199
| New | +$307K |
|
341
Digi International
DGII
$2.52B
| $288K | 0.13% |
10,366
-4,297
| -29% | -$133K |
|
342
American Financial Group
AFG
$11.9B
| $288K | 0.13% |
+2,189
| New | +$283K |
|
343
United Bankshares
UBSI
$6.55B
| $287K | 0.13% |
8,269
+1
| +0% | +$37 |
|
|
DAY
344
DELISTED
Dayforce
DAY
| $287K | 0.13% |
+4,914
| New | +$317K |
|
345
Parker-Hannifin
PH
$125B
| $286K | 0.13% |
+470
| New | +$307K |
|
346
Nasdaq
NDAQ
$51.5B
| $285K | 0.13% |
+3,763
| New | +$296K |
|
347
Graphic Packaging
GPK
$3.26B
| $285K | 0.13% |
+10,987
| New | +$294K |
|
348
First Industrial Realty Trust
FR
$8.88B
| $285K | 0.13% |
5,284
-3,975
| -43% | -$215K |
|
349
OraSure Technologies
OSUR
$273M
| $285K | 0.13% |
84,422
-16,783
| -17% | -$61.8K |
|
350
Artivion
AORT
$1.23B
| $284K | 0.13% |
+11,565
| New | +$321K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.